Objective: To investigate the efficacy of super-early minimally invasive operation accompanied with urokinase in the treatment of hypertensive intracerebral hemorrhage. Method: Selected minimally invasive operation accompanied with urokinase in the treatment of hypertensive intracerebral hemorrhage patients 82 cases,observe group 41 cases, super-early minimally invasive operation accompanied with urokinase; Control group 41 cases, delay minimally invasive operation. Compared the two groups about the short -term and long-term efficacy after surgery. Result: Hematoma evacuation completion time, days of hospital-ization in observe group was less than those in control group, There's significant difference (P<0.05). Compared the two groups,the cases of excellent, good, poor had significant difference(P<0.05). Conclusion: Super-early minimally invasive operation accompanied with urokinase in the treatment of hypertensive intracerebral hemorrhage, quickly remove the hematoma, safe, simple, effective, significantly improve patient survival rate and quality of life, worth clinical application.%目的:探讨超早期微创穿刺引流加尿激酶治疗高血压脑出血的疗效.方法:选择微创穿刺引流治疗高血压脑出血患者82例,观察组41例,采用超早期微创尿激酶溶解；对照组41例,采用延期微创冲洗引流.运用统计学方法,比较两组手术后近期和远期的疗效.结果:观察组血肿清除完成时间、住院天数均少于对照组,差异具有显著性,P＜0.05.观察组与对照组比较,优、良好、差三个方面的例数差异具有显著性,P＜0.05.结论:超早期微创穿刺引流加尿激酶治疗高血压脑出血可快速清除血肿、安全、简单、有效,明显提高患者生存率和生活质量,值得临床推广应用.
展开▼
